Get started
Work

The National Cardiovascular Data Registry Data Quality Program 2020

Year: 2022
Type: article
DOI: 10.1016/j.jacc.2022.02.034
Authors: David J. Malenka, Deepak L. Bhatt, Steven M. Bradley, David M. Shahian, Jasmine Draoui, Claire A. Segawa, Christina Koutras, Jinnette D. Abbott, James C. Blankenship, Robert Vincent, John Windle, Thomas T. Tsai, Jeptha Curtis, Matthew Roe, Frederick A. Masoudi
Institutions: Dartmouth–Hitchcock Medical Center, Brigham and Women's Hospital, Harvard University, Minneapolis Heart Institute Foundation, Massachusetts General Hospital, American College of Cardiology, Brown University, Rhode Island Hospital, Lifespan, University of New Mexico, Westchester Medical Center, New York Medical College, University of Nebraska Medical Center, Kaiser Permanente, University of Colorado Denver, Yale University, Duke University, Duke Medical Center, Duke Clinical Research Institute, Ascension
Language: English
Open Access status: bronze
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Sanofi, Patient-Centered Outcomes Research Institute, CSL Behring, Boston Scientific Corporation, Regeneron Pharmaceuticals, Cytokinetics, ReCor Medical, MyoKardia, Novo Nordisk, Genentech, Centers for Medicare and Medicaid Services, Janssen Pharmaceuticals
OpenAlex ID: W4224312401
FWCI: 6.29
Cites: 5
Cited by: 52
Related to: 10